Dyskeratotic marginal keratoconjunctivitis in hereditary periodontopathy and hyperkeratosis.
D000328:Adult; D001285:Atropine / Q000627:therapeutic use; D001706:Biopsy; D002648:Child; D002701:Chloramphenicol / Q000627:therapeutic use; D003228:Conjunctiva / Q000473:pathology; D003315:Cornea / Q000473:pathology; D007644:Darier Disease / Q000235:genetics / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D005500:Follow-Up Studies; D005885:Gingival Hyperplasia / Q000473:pathology; D006097:Granulation Tissue / Q000473:pathology; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D007637:Keratoconjunctivitis / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D010866:Natamycin / Q000627:therapeutic use; D009824:Ointments; D010118:Oxytetracycline / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D013577:Syndrome
D009824:Ointments; D011113:Polymyxins; D002701:Chloramphenicol; D001285:Atropine; D010866:Natamycin; D010118:Oxytetracycline